Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Director comp.
|
|
Orchestra BioMed Holdings, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/10/2023 |
8-K
| Quarterly results |
| 10/10/2023 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 09/29/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/10/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/12/2023 |
8-K
| Quarterly results |
| 06/12/2023 |
3
| Taylor Andrew Lawrence (CFO) has filed a Form 3 on Orchestra BioMed Holdings, Inc. |
| 06/12/2023 |
3
| Little William Reed (See Remarks) has filed a Form 3 on Orchestra BioMed Holdings, Inc. |
| 06/08/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/08/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 05/19/2023 |
4
| ROSE ERIC A MD (Director) has filed a Form 4 on Orchestra BioMed Holdings, Inc.|
Txns:
| Paid exercise price by delivering 157 shares
@ $16.04, valued at
$2.5k
Exercised 2,325 warrants
@ $1.08, valued at
$2.5k
|
|
| 05/19/2023 |
4/A
| ROSE ERIC A MD (Director) has filed a Form 4 on Orchestra BioMed Holdings, Inc.|
Txns:
| Granted 23,250 options to buy
@ $10, valued at
$232.5k
|
|
| 05/19/2023 |
4/A
| Mika Yuval (See Remarks) has filed a Form 4 on Orchestra BioMed Holdings, Inc.|
Txns:
| Granted 234,242 options to buy
@ $10, valued at
$2.3M
|
|
| 05/19/2023 |
4/A
| Kaswan Michael (CFO) has filed a Form 4 on Orchestra BioMed Holdings, Inc.|
Txns:
| Granted 192,566 options to buy
@ $10, valued at
$1.9M
|
|
| 05/19/2023 |
4/A
| Hochman David P (See Remarks) has filed a Form 4 on Orchestra BioMed Holdings, Inc.|
Txns:
| Granted 300,181 options to buy
@ $10, valued at
$3M
Granted 208,216 options to buy
@ $10, valued at
$2.1M
Granted 116,250 options to buy
@ $10, valued at
$1.2M
|
|
| 05/19/2023 |
4/A
| Fain Eric S (Director) has filed a Form 4 on Orchestra BioMed Holdings, Inc.|
Txns:
| Granted 23,250 options to buy
@ $10, valued at
$232.5k
|
|
| 05/19/2023 |
4/A
| Connealy Pamela Ann (Director) has filed a Form 4 on Orchestra BioMed Holdings, Inc.|
Txns:
| Granted 23,250 options to buy
@ $10, valued at
$232.5k
|
|
| 05/19/2023 |
4/A
| Aryeh Jason (Director) has filed a Form 4 on Orchestra BioMed Holdings, Inc.|
Txns:
| Granted 23,250 options to buy
@ $10, valued at
$232.5k
|
|
| 05/19/2023 |
4/A
| Aiello Joshua (Principal Accounting Officer) has filed a Form 4 on Orchestra BioMed Holdings, Inc.|
Txns:
| Granted 18,228 options to buy
@ $10, valued at
$182.3k
|
|
| 05/19/2023 |
4/A
| Sherman Darren (See Remarks) has filed a Form 4 on Orchestra BioMed Holdings, Inc.|
Txns:
| Granted 508,397 options to buy
@ $10, valued at
$5.1M
Granted 116,250 options to buy
@ $10, valued at
$1.2M
|
|
| 05/12/2023 |
4
| Fain Eric S (Director) has filed a Form 4 on Orchestra BioMed Holdings, Inc.|
Txns:
| Exercised 2,906 warrants
@ $1.08, valued at
$3.1k
|
|
| 05/12/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/08/2023 |
4
| Smith Geoffrey Wade (Director) has filed a Form 4 on Orchestra BioMed Holdings, Inc.|
Txns:
| Exercised 758 options to buy
@ $0
Exercised 43,761 options to buy
@ $0
Exercised 228,073 options to buy
@ $0
Exercised 55,783 options to buy
@ $0 |
|
| 05/08/2023 |
4/A
| Smith Geoffrey Wade (Director) has filed a Form 4 on Orchestra BioMed Holdings, Inc.|
Txns:
| Granted 1,516 options to buy
@ $0
Granted 87,522 options to buy
@ $0
Granted 456,146 options to buy
@ $0
Granted 111,566 options to buy
@ $0 |
|
|
|
|